Calidi Biotherapeutics CLDI Insider Ownership

NYSE CLDI
$0.68 -0.08 (-10.72%)
As of: Oct 22, 2026 · 11:54 AM EDT

Insider Holdings by Owner

21.42K Shares

Insider Ownership Statistics

as of 30 Sep, 2026
Insider Ownership
1.44%
■0% pp QoQ
Shares Held by Insiders
20.45K
filed for Sep 2026
■0.00% QoQ
Shares Outstanding
1.42Mn
1,416,000 shares
Direct Holdings
15.14K
Indirect: 5.31K
Net Shares Traded (QoQ)
0
no net change in Sep 2026
Insiders Holding Shares
10
with Form 4 holdings on file

Shares Owned by Insiders

Shares held % of outstanding
Latest —
Average ownership —
Peak ownership —

Shares Purchased/Sold by Insiders

Bought Sold
Latest quarter —
Net over range —
Buying quarters —

Insider Ownership Summary

Over the past year, CLDI insiders sold $1,237 of stock on the open market and bought none.

Form 4 Holdings

Insiders Holding CLDI

Insiders 10
Shares held 21.42K
Of outstanding 1.51%
# Insider Position Direct Indirect Total Share of Insiders Last Filed
1 Scott Leftwich Director 8,166 0 8,166 38.1% 25 Aug, 2025
2 Allan Camaisa Director 0 4,810 4,810 22.5% 16 Dec, 2025
3 James A Schoeneck Director 4,758 0 4,758 22.2% 25 Aug, 2025
4 Eric E Poma Chief Executive Officer 1,563 0 1,563 7.3% 25 Aug, 2025
5 Light Acquisition Group, Llc First Chief Executive Officer 0 1,342 1,342 6.3% 14 Sep, 2022
6 Asset Management Partners Inc. Polar TenPercentOwner 0 215 215 1.0% 21 Oct, 2022
7 Thomas A. Vecchiolla Director 193 0 193 0.9% 26 Dec, 2023
8 Andrew C. Jackson Chief Financial Officer 156 0 156 0.7% 25 Aug, 2025
9 Alan R. Stewart Director 151 0 151 0.7% 03 Jan, 2025
10 Alfonso G Zulueta Director 69 0 69 0.3% 04 Jan, 2024

Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.

Form 4 Filings

69 Insider Transactions

Source SEC Form 4
Latest quarter Sep 2026
Download Data
Date Insider Position Transaction Shares Price Value Shares Held After Ownership
17 Aug, 2026 Eric E Poma Chief Executive Officer Acquired A 32,000 — — 32,000 Direct
17 Aug, 2026 James A Schoeneck Director Acquired A 5,000 $0.00 $0 5,000 Direct
17 Aug, 2026 George Peoples Director Acquired A 4,000 $0.00 $0 4,000 Direct
17 Aug, 2026 Corazon (Corsee) D. Sanders Director Acquired A 6,000 $0.00 $0 6,000 Direct
17 Aug, 2026 Santidrian Antonio Fernandez Chief Scientific Officer Acquired A 16,000 — — 16,000 Direct
17 Aug, 2026 Andrew C. Jackson Chief Financial Officer Acquired A 14,000 — — 14,000 Direct
17 Aug, 2026 Scott Leftwich Director Acquired A 4,000 $0.00 $0 4,000 Direct
17 Aug, 2026 Alan R. Stewart Director Acquired A 4,000 $0.00 $0 4,000 Direct
12 Dec, 2025 Allan Camaisa Director Disposed S 850 $23.28 $19.79K 4,810 Indirect
03 Sep, 2025 Andrew C. Jackson Chief Financial Officer Acquired A 30,000 — — 1,875 Direct
03 Sep, 2025 Santidrian Antonio Fernandez Chief Scientific Officer Acquired A 35,000 — — 2,188 Direct
03 Sep, 2025 Eric E Poma Chief Executive Officer Acquired A 10,000 — — 625 Direct
21 Aug, 2025 Scott Leftwich Director Acquired P 125,000 $32.00 $4.00Mn 8,166 Direct
21 Aug, 2025 Andrew C. Jackson Chief Financial Officer Acquired P 2,500 $32.00 $80.00K 156 Direct
21 Aug, 2025 James A Schoeneck Director Acquired P 75,000 $32.00 $2.40Mn 4,758 Direct
21 Aug, 2025 Eric E Poma Chief Executive Officer Acquired P 25,000 $32.00 $800.00K 1,563 Direct
21 Aug, 2025 Eric E Poma Chief Executive Officer Acquired P 25,000 — — 1,563 Direct
21 Aug, 2025 Andrew C. Jackson Chief Financial Officer Acquired P 2,500 — — 156 Direct
21 Aug, 2025 James A Schoeneck Director Acquired P 75,000 — — 4,688 Direct
21 Aug, 2025 Scott Leftwich Director Acquired P 125,000 — — 7,813 Direct